✦ LIBER ✦

111 Comparison of two inhaled tobramycin solutions in cystic fibrosis patients with chronic Pseudomonas aeruginosa infection: results in different age subgroups

✍ Scribed by H. Mazurek; R. Chiron; L. Pelikan; C. Geidel; K. Bolbas; Y. Antipkin; M.A. Blanco; G. Varoli; D. Santoro; H. Cicirello; A. Chuchalin

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

110 Head-to-head comparison of two inhal

✍ H. Mazurek; G. Lenoir; L. Pelikan; C. Geidel; K. Bolbas; Y. Antipkin; M.A. Blanc 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Inhaled Tobramycin in Non-Cystic Fibrosi

✍ Drobnic, M E. 📂 Article 📅 2005 🏛 Harvey Whitney Books Company 🌐 English ⚖ 56 KB

82* Microbiological and clinical respons

✍ D.E. Geller; P.A. Flume; M. Konstan; G. Angyalosi; M. Higgins 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Efficiency of the inhalational tobramyci

✍ S.Y. Semykin; S.V. Polikarpova; L.G. Dubovik; N.Y. Kashirskaya 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Budget Impact Analysis Of The Use Of Tob

✍ Lemus, A.; Rosas, J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

WS7.3 Once-daily liposomal amikacin for

✍ Bilton, D.; Pressler, T.; Fajac, I.; Clancy, J.P.; Sands, D.; Minic, P.; Cipolli 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 65 KB